Three single nucleotide polymorphisms of the vascular endothelial growth factor (VEGF) gene and glioma risk in a Chinese population

Journal of International Medical Research

Volumn 41, Issue 5, 2013, Pages 1484-1494

  Jiang, Haitao ^a   Lian, Minxue ^a   Xie, Jiangtao ^a   Li, Jinzheng ^a   Wang, Maode ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

gene polymorphism; Glioma; vascular endothelial growth factor; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER RISK; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GLIOBLASTOMA; GLIOMA; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; VEGF GENE;

GENE POLYMORPHISM; GLIOMA; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; GENE FREQUENCY; GENOTYPE; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROMOTER REGIONS, GENETIC; RISK; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84887289763     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513498667     Document Type: Article

References (45)

1. Jemal A,Siegel R,Ward E, et al.Cancer statistics, 2009.CA Cancer J Clin. 2009;59:225-249.
2. Ohgaki H,Kleihues P.Epidemiology and etiology of gliomas.Acta Neuropathol. 2005;109:93-108.
3. Jakola AS,Myrmel KS,Kloster R, et al.Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas.JAMA. 2012;308:1881-1888.
4. Fuller GN,Scheithauer BW.The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities.Brain Pathol. 2007;17:304-307.
5. Thurnher MM.2007 World Health Organization classification of tumours of the central nervous system.Cancer Imaging. 2009;9 Spec No A:S1-S3.
6. Samkange-Zeeb F,Schlehofer B,Schüz J, et al.Occupation and risk of glioma, meningioma and acoustic neuroma: results from a German case-control study (interphone study group, Germany).Cancer Epidemiol. 2010;34:55-61.
7. De Roos AJ,Stewart PA,Linet MS, et al.Occupation and the risk of adult glioma in the United States.Cancer Causes Control. 2003;14:139-150.
8. Maker HS,Syed H,Whetsell W, et al.Environmental factors modifying the effect of CCNU on glioma in vitro and in vivo.Trans Am Neurol Assoc. 1976;101:273-275.
9. Bunin GR,Kuijten RR,Boesel CP, et al.Maternal diet and risk of astrocytic glioma in children: a report from the Childrens Cancer Group (United States and Canada).Cancer Causes Control. 1994;5:177-187.
10. Shete S,Hosking FJ,Robertson LB, et al.Genome-wide association study identifies five susceptibility loci for glioma.Nat Genet. 2009;41:899-904.
11. Wrensch M,Jenkins RB,Chang JS, et al.Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.Nat Genet. 2009;41:905-908.
12. Roy H,Bhardwaj S,Yla-Herttuala S.Biology of vascular endothelial growth factors.FEBS Lett. 2006;580:2879-2887.
13. Belinsky GS,Claffey KP,Nambiar PR, et al.Vascular endothelial growth factor and enhanced angiogenesis do not promote metastatic conversion of a newly established azoxymethane-induced colon cancer cell line.Mol Carcinog. 2005;43:65-74.
14. Vincenti V,Cassano C,Rocchi M, et al.Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3.Circulation. 1996;93:1493-1495.
15. Watson CJ,Webb NJ,Bottomley MJ, et al.Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production.Cytokine. 2000;12:1232-1235.
16. Bae SJ,Ahn DH,Hong SP, et al.Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer.Yonsei Med J. 2008;49:783-791.
17. Renner W,Kotschan S,Hoffmann C, et al.A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels.J Vasc Res. 2000;37:443-448.
18. Lee SJ,Lee SY,Jeon HS, et al.Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer.Cancer Epidemiol Biomarkers Prev. 2005;14:571-575.
19. Dassoulas K,Gazouli M,Rizos S, et al.Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival.Mol Carcinog. 2009;48:563-569.
20. Krippl P,Langsenlehner U,Renner W, et al.A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk.Int J Cancer. 2003;106:468-471.
21. Yapijakis C,Vairaktaris E,Vassiliou S, et al.The low VEGF production allele of the +936 C/T polymorphism is strongly associated with increased risk for oral cancer.J Cancer Res Clin Oncol. 2007;133:787-791.
22. Smerdel MP,Steffensen KD,Waldstrøm M, et al.The predictive value of serum VEGF in multiresistant ovarian cancer patients treated with bevacizumab.Gynecol Oncol. 2010;118:167-171.
23. Zhou Y,Li N,Zhuang W, et al.Vascular endothelial growth factor (VEGF) gene polymorphisms and gastric cancer risk in a Chinese Han population.Mol Carcinog. 2011;50:184-188.
24. García-Closas M,Malats N,Real FX, et al.Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk.PLoS Genet. 2007;3:e29-e29.
25. Bao G,Wang M,Guo S, et al.Vascular endothelial growth factor +936 C/T gene polymorphism and glioma risk in a Chinese Han population.Genet Test Mol Biomarkers. 2011;15:103-106.
26. Li R,Zhao Y,Fan W, et al.Possible association between polymorphisms of human vascular endothelial growth factor A gene and susceptibility to glioma in a Chinese population.Int J Cancer. 2011;128:166-175.
27. Sawaji Y,Sato T,Takeuchi A, et al.Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro.Br J Cancer. 2002;86:1597-1603.
28. Salven P,Mänpää H,Orpana A, et al.Serum vascular endothelial growth factor is often elevated in disseminated cancer.Clin Cancer Res. 1997;3:647-651.
29. Ferrara N.VEGF and the quest for tumour angiogenesis factors.Nat Rev Cancer. 2002;2:795-803.
30. Iordache S,Saftoiu A,Georgescu CV, et al.Vascular endothelial growth factor expression and microvessel density - two useful tools for the assessment of prognosis and survival in gastric cancer patients.J Gastrointestin Liver Dis. 2010;19:135-139.
31. Perrone G,Vincenzi B,Santini D, et al.Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer.Cancer Lett. 2004;208:227-234.
32. Stefanou D,Batistatou A,Kamina S, et al.Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer.In Vivo. 2004;18:155-160.
33. Prior SJ,Hagberg JM,Paton CM, et al.DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption.Am J Physiol Heart Circ Physiol. 2006;290:H1848-H1855.
34. Guan X,Zhao H,Niu J, et al.The VEGF -634G > C promoter polymorphism is associated with risk of gastric cancer.BMC Gastroenterol. 2009;9:77-77.
35. Jakubowska A,Gronwald J,Menkiszak J, et al.The VEGF_936_C > T 3′UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women.Cancer Lett. 2008;262:71-76.
36. Rodrigues P,Furriol J,Tormo E, et al.The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population.Breast Cancer Res Treat. 2012;133:769-778.
37. Bae SJ,Kim JW,Kang H, et al.Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C > T) gene and colon cancer in Korea.Anticancer Res. 2008;28:1271-1276.
38. Zhao Z,Ba C,Wang W, et al.Vascular endothelial growth factor (VEGF) gene polymorphisms and colorectal cancer: a meta-analysis of epidemiologic studies.Genet Test Mol Biomarkers. 2012;16:1390-1394.
39. Li Y,Liang J,Liu X, et al.Correlation of polymorphisms of the vascular endothelial growth factor gene and the risk of lung cancer in an ethnic Han group of North China.Exp Ther Med. 2012;3:673-676.
40. Wei X,Chen D,Lv T.A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis.Mol Biol Rep. 2013;40:567-572.
41. Sun JY,Zhang CY,Zhang ZJ, et al.Association between XRCC1 gene polymorphisms and risk of glioma development: a meta-analysis.Asian Pac J Cancer Prev. 2012;13:4783-4788.
42. Luo KQ,Mu SQ,Wu ZX, et al.Polymorphisms in DNA repair genes and risk of glioma and meningioma.Asian Pac J Cancer Prev. 2013;14:449-452.
43. Fan Z,Wu Y,Shen J, et al.Glutathione S-transferase M1, T1, and P1 polymorphisms and risk of glioma: a meta-analysis.Mol Biol Rep. 2013;40:1641-1650.
44. Li Y,Zhao Y,Liu J, et al.A functional polymorphism in the epidermal growth factor gene is associated with risk for glioma in a Chinese population.Genet Test Mol Biomarkers. 2012;16:449-452.
45. Chen DQ,Yao DX,Zhao HY, et al.DNA repair gene ERCC1 and XPD polymorphisms predict glioma susceptibility and prognosis.Asian Pac J Cancer Prev. 2012;13:2791-2794.